Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease-Reference-Cited by-同舟云学术

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Published:2012-08-30 Issue:9 Volume:367 Page:795-804
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Bateman Randall J.,Xiong Chengjie,Benzinger Tammie L.S.,Fagan Anne M.,Goate Alison,Fox Nick C.,Marcus Daniel S.,Cairns Nigel J.,Xie Xianyun,Blazey Tyler M.,Holtzman David M.,Santacruz Anna,Buckles Virginia,Oliver Angela,Moulder Krista,Aisen Paul S.,Ghetti Bernardino,Klunk William E.,McDade Eric,Martins Ralph N.,Masters Colin L.,Mayeux Richard,Ringman John M.,Rossor Martin N.,Schofield Peter R.,Sperling Reisa A.,Salloway Stephen,Morris John C.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1202753

Cited by 3047 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults;Neurobiology of Aging;2024-12

2. Apolipoprotein E4 and Alzheimer's disease causality under adverse environments and potential intervention by senolytic nutrients;Clinical Nutrition ESPEN;2024-12

3. Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease;Neurology;2024-10-08

4. Cerebral glucose metabolism in Alzheimer's disease;Cortex;2024-10

5. Edaravone N-benzyl pyridinium derivatives: BACE-1 inhibition, kinetics and in silico binding pose determination;European Journal of Pharmaceutical Sciences;2024-10